SCHEMBL5501185

SCHEMBL5501185

O=C(CN1CCCC1CN1CCCC1)Nc1ccc(Nc2ncc(-c3ccsc3)cn2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 3/20 0.38
ALDH1A1 P00352 5/20 0.38
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
L3MBTL1 Q9Y468 2/20 0.38
GAA P10253 2/20 0.38
RAD52 P43351 2/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
PORCN Q9H237 2/20 0.37
MCHR1 Q99705 1/20 0.37
CTSC P53634 1/20 0.37
KDM4E B2RXH2 4/20 0.36
THRB P10828 1/20 0.36
ATR Q13535 1/20 0.36
CYP3A4 P08684 1/20 0.36
GRIN2B Q13224 1/20 0.36
NPC1 O15118 3/20 0.36
HPGD P15428 2/20 0.36
HTT P42858 1/20 0.36
TDP1 Q9NUW8 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5521372 0.91 POLB (0.43) ALDH1A1SMN1; SMN2MCHR1CTSCKDM4E
SCHEMBL5499974 0.87 KDM4E (0.49) HRH3ALDH1A1MEN1KMT2AL3MBTL1
SCHEMBL5521720 0.85 HRH3 (0.43) HRH3ALDH1A1ATRMAPT
SCHEMBL5496779 0.83 KDM4E (0.51) HRH3ALDH1A1MCHR1KDM4ETHRB
SCHEMBL5500635 0.81 HRH3 (0.43) HRH3ALDH1A1SMN1; SMN2PORCNCTSC
SCHEMBL5496170 0.79 MGLL (0.48) ALDH1A1MEN1KMT2AGAASMN1; SMN2
SCHEMBL5494719 0.78 ATM (0.52) HRH3ALDH1A1SMN1; SMN2KDM4ENPC1
SCHEMBL5503212 0.78 POLB (0.57) ALDH1A1GAASMN1; SMN2CTSCKDM4E
SCHEMBL5499872 0.78 THRB (0.50) GAATHRBPOLBMAPTTP53
SCHEMBL14342345 0.77 MAPT (0.48) HRH3ALDH1A1SMN1; SMN2CTSCATR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070293484-A1 Thiophene Heteroaryl Amines SUGEN, INC. 2007-12-20 US claimed
EP-1753750-A1 THIOPHENE HETEROARYL AMINES Sugen, Inc. (US) 2007-02-21 EP claimed
WO-2005113548-A1 THIOPHENE HETEROARYL AMINES SUGEN, INC. (US) 2005-12-01 WO claimed
US-20070293484-A1 Thiophene Heteroaryl Amines SUGEN, INC. 2007-12-20 US disclosed
US-20070293484-A1 Thiophene Heteroaryl Amines SUGEN, INC. 2007-12-20 US disclosed
US-20070293484-A1 Thiophene Heteroaryl Amines SUGEN, INC. 2007-12-20 US disclosed
EP-1753750-A1 THIOPHENE HETEROARYL AMINES Sugen, Inc. (US) 2007-02-21 EP disclosed
WO-2005113548-A1 THIOPHENE HETEROARYL AMINES SUGEN, INC. (US) 2005-12-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070293484-A1 Thiophene Heteroaryl Amines TTK, CHEK2, ABL1 HRH3 1572/4885ALDH1A1 3195/4885MEN1 3002/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.